Ultragenyx Pharmaceutical, Inc. (RARE)

22.59 +0.10 (+0.44%) USD  |  NASDAQ  |  Jan 20, 13:26
More

Ultragenyx Pharmaceutical Consensus Recommendation

Consensus Recommendation Chart

View Consensus Recommendation for RARE.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Consensus Recommendation Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Consensus Recommendation Range, Past 5 Years

View Consensus Recommendation Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Consensus Recommendation Benchmarks

View Consensus Recommendation Benchmarks
Start Trial
Corcept Therapeutics, Inc. Upgrade
Johnson & Johnson Upgrade
CorMedix, Inc. Upgrade
Amicus Therapeutics, Inc. Upgrade
Geron Corp. Upgrade